Skip to main content

Vildagliptin (International)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A10BH02

CAS registry number (Chemical Abstracts Service)

0274901-16-5

Chemical Formula

C17-H25-N3-O2

Molecular Weight

303

Therapeutic Category

Oral antidiabetic agent: Dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin

Chemical Names

(S)-{[(3-Hydroxyadamantan-1-yl)amino]acetyl}pyrrolidin-2-carbonitril (IUPAC)

(2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile (WHO)

2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-

Foreign Names

  • Vildagliptinum (Latin)
  • Vildagliptin (German)
  • Vildagliptine (French)
  • Vildagliptina (Spanish)

Generic Names

  • Vildagliptin (OS: USAN, BAN, JAN)
  • DPP-728 (IS)
  • DPP-728A (IS)
  • LAF-237 (IS)
  • NVP-DPP-728 (IS)
  • NVP-LAF-237 (IS)

Brand Names

  • Agnis
    Belupo, Poland; Belupo, Slovenia; Farmavita, Bosnia & Herzegowina
  • Dalmevin
    Medochemie, Malta; Medochemie, Romania; Medochemie, Sweden
  • Daltex [+ Metformin]
    Medochemie, Romania
  • Equa
    Novartis, Japan
  • EquMet HD [+ Metformin]
    Novartis, Japan
  • EquMet LD [+ Metformin]
    Novartis, Japan
  • Eucreas [+ Metformin]
    Farmagon, Norway; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Czech Republic; Novartis, Denmark; Novartis, Estonia; Novartis, Finland; Novartis, France; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Ireland; Novartis, Lithuania; Novartis, Latvia; Novartis, Netherlands; Novartis, Norway; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis Europharm, Cyprus; Novartis Europharm, Romania; Novartis Europharm, Slovenia; Novartis Europharm Limited, Iceland; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals UK, United Kingdom; Orifarm, Norway
  • Eucreas 50 mg/1000 mg [+ Metformin]
    Novartis, Hungary
  • Eucreas 50 mg/850 mg [+ Metformin]
    Novartis, Hungary
  • Eucreas 50/1000mg [+ Metformin]
    Novartis, Israel; Novartis, Luxembourg; Novartis Europharm, Austria
  • Eucreas 50/500mg [+ Metformin]
    Novartis, Israel
  • Eucreas 50/850mg [+ Metformin]
    Novartis, Israel; Novartis, Luxembourg; Novartis Europharm, Austria
  • Galiptin [+ Metformin]
    Farmanova, Turkey
  • Galvumet [+ Metformin]
    Novartis, New Zealand; Novartis, Tunisia; Novartis Pharmaceuticals, Australia
  • Galvumet 50/1000mg [+ Metformin]
    Novartis Pharma, Switzerland
  • Galvumet 50/500mg [+ Metformin]
    Novartis Pharma, Switzerland
  • Galvumet 50/850mg [+ Metformin]
    Novartis Pharma, Switzerland
  • Galvus
    Beijing Novartis Pharma Co., Ltd., China; Dexa Medica, Indonesia; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, Colombia; Novartis, Czech Republic; Novartis, Denmark; Novartis, Ecuador; Novartis, Estonia; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Indonesia; Novartis, Ireland; Novartis, South Korea; Novartis, Lebanon; Novartis, Lithuania; Novartis, Mexico; Novartis, Malaysia; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Pakistan; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Uruguay; Novartis AH, South Africa; Novartis Biosciences, Peru; Novartis Europharm, Cyprus; Novartis Europharm, Greece; Novartis Europharm, Romania; Novartis Europharm Limited, Iceland; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Healthcare, Philippines; Novartis Pharma, Russian Federation; Novartis PHarma Services Inc., Serbia; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals UK, United Kingdom; Novartis Singapore, Singapore
  • Galvus 50mg
    Novartis, Hungary; Novartis, Israel; Novartis Europharm, Austria; Novartis Pharma, Switzerland
  • Galvus Met [+ Metformin]
    Novartis, Chile; Novartis, Colombia; Novartis, Ecuador; Novartis, Egypt; Novartis, Georgia; Novartis, Hong Kong; Novartis, Lebanon; Novartis, Mexico; Novartis, Malaysia; Novartis, Oman; Novartis, Thailand; Novartis, Uruguay; Novartis AH, South Africa; Novartis Biosciences, Peru; Novartis Pharma, Russian Federation
  • Galvus MET 50/1000 [+ Metformin]
    Novartis, Argentina
  • Galvus MET 50/850 [+ Metformin]
    Novartis, Argentina
  • Galvus Met Combo-Pack [+ Metformin]
    Novartis, Brazil
  • Galvusmet [+ Metformin]
    Novartis, Indonesia; Novartis, South Korea; Novartis Healthcare, Philippines; Novartis Singapore, Singapore
  • Galvus-Met [+ Metformin]
    Novartis, Pakistan; Novartis, Turkey
  • Galza
    CCL, Pakistan
  • Galza-Met [+ Metformin]
    CCL, Pakistan
  • Gambaran 500mg
    Novartis, Luxembourg
  • Gericap [+ Metformin]
    Polyfine, Pakistan
  • Glucemix
    Bago, Argentina
  • Glucemix Met [+ Metformin]
    Bago, Argentina
  • Glypvilo
    KRKA, Slovenia
  • Icandra [+ Metformin]
    Mylan, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Romania; Novartis Europharm, Slovenia
  • Jalra
    Laboratorios Dr. Esteve, Spain; Merck, Chile; Novartis, Denmark; Novartis, Estonia; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Romania; Novartis, Slovenia
  • Jalra M [+ Metformin]
    Merck, Chile
  • Jalra-M [+ Metformin]
    Merck, Mexico
  • Metliptin [+ Metformin]
    Tabros, Pakistan
  • Proglin
    LR Imperial, Philippines
  • Saxotin
    Lek, Bulgaria; Novartis Pharma, Bulgaria; Salutas Pharma, Bulgaria; Sandoz, Estonia; Sandoz, Latvia; Sandoz, Slovenia
  • Viglita
    Square, Bangladesh
  • Vildagliptin
    Alfred E Tiefenbacher, Malta
  • Vildagliptine Sandoz
    Sandoz, Netherlands
  • Vildagliptine/Metformine Sandoz [+ Metformin]
    Sandoz, Netherlands
  • Vilget
    Getz Pharma, Georgia
  • Vilspox [+ Metformin]
    Lek, Bulgaria; Lek Pharmaceuticals, Bulgaria; Novartis Pharma, Bulgaria; Salutas Pharma, Bulgaria; Sandoz, Estonia; Sandoz, Latvia; Sandoz, Slovenia
  • Viptin
    General Pharma, Bangladesh
  • Xiliarx
    Mylan, Spain; Novartis, Estonia; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Romania; Novartis, Slovenia
  • Xiliarxs
    Sanfer, Mexico
  • Xiliarxs Duo [+ Metformin]
    Sanfer, Mexico
  • Zomarist
    Montpellier, Argentina
  • Zomarist [+ Metformin]
    Laboratorios Dr. Esteve, Spain; Novartis, Estonia; Novartis, Greece; Novartis, Croatia (Hrvatska); Novartis, Lithuania; Novartis, Netherlands; Novartis, Poland; Novartis, Portugal; Novartis, Sweden; Novartis Europharm, Romania; Novartis, Slovenia
  • Zomarist Met [+ Metformin]
    Montpellier, Argentina
  • Zomelis
    AHPL, India
  • Zomelis-MET [+ Metformin]
    AHPL, India

Glossary

TermDefinition
BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.